The Global Cancer Diversity Atlas (GCDA) is a comprehensive oncology data resource designed to capture, analyze, and interpret genomic diversity across underrepresented cancer populations. It consolidates multidimensional data—including tumor genomics, germline variants, liquid biopsy insights, and clinical outcomes—to help clinicians, researchers, and pharmaceutical teams improve therapeutic decision‑making.

OncoTwin Insights is an AI‑powered clinical intelligence platform designed to unify clinicogenomic data, real‑world evidence, and patient similarity modeling to support more informed oncology decision‑making. By matching each patient with clinically similar “twins,” the platform provides treatment insights, outcome expectations, and biomarker‑driven therapy guidance.

OncoBuddy is a digital oncology companion platform that supports patients and clinicians throughout the cancer‑care journey. It unifies clinical data, patient‑reported outcomes, and personalized guidance in one intuitive interface.

4basecare’s Genomic Tests comprise a comprehensive suite of precision‑oncology assays designed to reveal actionable genomic alterations across a wide range of cancer types. These tests integrate tumor, germline, and liquid‑biopsy insights to support personalized treatment planning.